A detailed history of Rafferty Asset Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 159,895 shares of BSX stock, worth $13.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
159,895
Previous 151,189 5.76%
Holding current value
$13.6 Million
Previous $10.4 Million 18.92%
% of portfolio
0.05%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $586,174 - $676,543
8,706 Added 5.76%
159,895 $12.3 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $122,860 - $146,366
2,133 Added 1.43%
151,189 $10.4 Million
Q4 2023

Feb 13, 2024

SELL
$48.64 - $57.81 $181,135 - $215,284
-3,724 Reduced 2.44%
149,056 $8.62 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $683,788 - $744,960
13,624 Added 9.79%
152,780 $8.07 Million
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $546,422 - $600,493
10,990 Added 8.57%
139,156 $7.53 Million
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $222,383 - $246,747
4,932 Added 4.0%
128,166 $6.41 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $1.85 Million - $2.2 Million
46,641 Added 60.89%
123,234 $5.7 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $1.54 Million - $4.6 Million
41,908 Added 120.82%
76,593 $2.97 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $312,684 - $417,918
-8,873 Reduced 20.37%
34,685 $1.29 Million
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $177,383 - $195,598
-4,337 Reduced 9.06%
43,558 $1.93 Million
Q4 2021

Feb 10, 2022

BUY
$38.07 - $44.87 $95,098 - $112,085
2,498 Added 5.5%
47,895 $2.04 Million
Q3 2021

Nov 10, 2021

BUY
$41.23 - $45.88 $659,061 - $733,391
15,985 Added 54.35%
45,397 $1.97 Million
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $103,047 - $118,165
2,671 Added 9.99%
29,412 $1.26 Million
Q1 2021

May 10, 2021

BUY
$35.27 - $39.67 $110,677 - $124,484
3,138 Added 13.29%
26,741 $1.03 Million
Q4 2020

Feb 10, 2021

SELL
$33.15 - $41.97 $73,493 - $93,047
-2,217 Reduced 8.59%
23,603 $849,000
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $216,352 - $265,288
-6,282 Reduced 19.57%
25,820 $987,000
Q2 2020

Aug 07, 2020

BUY
$30.19 - $39.11 $645,371 - $836,054
21,377 Added 199.32%
32,102 $1.13 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $695,162 - $1.23 Million
-26,913 Reduced 71.5%
10,725 $350,000
Q4 2019

Feb 10, 2020

BUY
$37.87 - $45.37 $1.43 Million - $1.71 Million
37,638 New
37,638 $1.7 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.